Director, Medical Reviewer
- Employer
- Daiichi Sankyo
- Location
- Basking Ridge, New Jersey
- Start date
- Jul 16, 2021
View more
- Discipline
- Clinical, Clinical Development, Clinical Medicine, Science/R&D, Pharmacology
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Pharm Country
Job Details
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Job Summary:
The Medical Review Clinical Safety Director is responsible for expert review, assessment and applicable communication of individual case reports (ICSRs) arising from all DSI investigational and marketed products. The Director may also manage contractors performing these key responsibilities.
Responsibilities:
- Overall: Provides expert medical review, assessment and communication of ICSRs in both the investigational and marketed settings. Ensures that ICSR reporting meets all relevant internal timelines. Performs all key responsibilities with minimum supervision.
- Medical Assessment: Provides medical review and assessment of ICSRs, including evaluation of the case narrative for accuracy, medical logic and completeness and review of coding and expectedness (against relevant reference documents). Uses medical knowledge, product knowledge and experience to determine potential causes of reported adverse events. Determines or confirms the company causality and authors or oversees the causality statement. As requested by management, participates in safety meetings to enhance medical assessment of adverse events of special interest or complex adverse events. May perform weekly literature review to identify ICSRs as required by regulations.
- Reporting and Regulatory Compliance: Ultimately decides if an adverse event is an expeditable report. Maintains knowledge and follows regulatory guidance, protocol requirements and department processes for proper ICSR handling. From a medical perspective, ensures that ICSRs are reported within all relevant internal timelines. Anticipates problems with compliance and creates solutions in a timely manner.
- Communication: Fosters and maintains a communication channel to SMTs or Clinical Safety physicians assigned to DSI products: communicates clinically notable adverse events to SMTs/assigned physicians; appropriately reacts to new information provided by SMTs/CS physicians. Maintains regular and strong communication with other DS regions in Japan and Europe. Engages other relevant stakeholders such as CROs and Clinical Operations to provide robust ICSR management. Reviews ICSR-related external communications such as analyses of similar events. Escalates problems to management.
- Quality and Training: Participates in safety specialist training. Reviews case line listings to ensure that coding, expectedness and medical evaluation are accurate. May support management in developing other methods and/or remedies to ensure high quality medical review of DSI products.
Education/Experience:
- MD/DO required
- Board certification or eligibility
- At least 3-5 years of experience in the pharmaceutical industry, regulatory agency or academia, with exposure to drug development, clinical pharmacology, and/or epidemiology
Company
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.
With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
For more information, please visit: www.daiichisankyo.com.
Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is a member of the Daiichi Sankyo Group. To learn more about Daiichi Sankyo, Inc., please visit www.dsi.com.
STOCK EXCHANGE: Tokyo Stock Exchange
STOCK SYMBOL: 4568
- Website
- http://www.daiichisankyo.com/
- Phone
- (908) 992-6400
- Location
-
211 Mt. Airy Road
Basking Ridge
New Jersey
07920
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert